Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05%
Product Images NDC 72934-1050

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05% (NDC 72934-1050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D (2 End)

Partial label on a white container for CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% by Sincerus Florida, LLC. The visible label includes directions for use, manufacturer address in Pompano Beach, FL, a contact phone number, and storage instructions at controlled room temperature (20-25°C). A small QR code is also visible.*

FDA Label Image

D (1050 2 Front)

Packaging label of a compounding gel product containing Clindamycin Phosphate USP 1%, Niacinamide USP 2%, and Tazarotene 0.05%. The label shows the NDC 72934-1050-2 and states the gel size as 30 grams. The labeler is Sincerus Florida, LLC, and it is made in the USA.*

FDA Label Image

S (1050 2 Middle)

Label of CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05% topical gel showing active ingredients Clindamycin Phosphate USP 1%, Niacinamide USP 2%, and Tazarotene 0.05%. Inactive ingredient is a Suspensisse Gel at 96.95%. The label includes RX only designation and lot/mfg dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.